These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 7199538

  • 1. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y, Aoki N.
    J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
    [Abstract] [Full Text] [Related]

  • 2. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC, Abdul S, Malfliet JJ, Leebeek FW, Uitte de Willige S.
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [Abstract] [Full Text] [Related]

  • 3. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y, Aoki N.
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [Abstract] [Full Text] [Related]

  • 4. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
    Aoki N, Sakata Y, Ichinose A.
    Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor.
    Kimura S, Tamaki T, Aoki N.
    Blood; 1985 Jul; 66(1):157-60. PubMed ID: 3159442
    [Abstract] [Full Text] [Related]

  • 7. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
    Koncz Z, Bagoly Z, Haramura G, Mezei ZA, Muszbek L.
    Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
    [Abstract] [Full Text] [Related]

  • 8. Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.
    Sakata Y, Eguchi Y, Mimuro J, Matsuda M, Sumi Y.
    Blood; 1989 Dec; 74(8):2692-7. PubMed ID: 2510836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency.
    Sakata Y, Mimuro J, Aoki N.
    Blood; 1984 Jun; 63(6):1393-401. PubMed ID: 6232970
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M, Watanuki M, Matsuo O.
    Biochem Biophys Res Commun; 1989 Jul 31; 162(2):830-7. PubMed ID: 2527034
    [Abstract] [Full Text] [Related]

  • 12. The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.
    Ichinose A, Aoki N.
    Thromb Res; 1986 Mar 15; 41(6):847-54. PubMed ID: 2939589
    [Abstract] [Full Text] [Related]

  • 13. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.
    Hethershaw EL, Cilia La Corte AL, Duval C, Ali M, Grant PJ, Ariëns RA, Philippou H.
    J Thromb Haemost; 2014 Feb 15; 12(2):197-205. PubMed ID: 24261582
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E, Rouy D, Lijnen HR.
    Biochim Biophys Acta; 1992 Dec 08; 1156(1):34-42. PubMed ID: 1472536
    [Abstract] [Full Text] [Related]

  • 15. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG, Steenwyk BL, Gurley WQ.
    J Heart Lung Transplant; 2006 Oct 08; 25(10):1247-52. PubMed ID: 17045938
    [Abstract] [Full Text] [Related]

  • 16. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
    Takada A, Watahiki Y, Takada Y.
    Thromb Res; 1986 Mar 01; 41(5):605-13. PubMed ID: 3083529
    [Abstract] [Full Text] [Related]

  • 17. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
    Ries M, Klinge J, Rauch R, Keuper H, Harms D.
    Biol Neonate; 1996 Mar 01; 69(5):298-306. PubMed ID: 8790908
    [Abstract] [Full Text] [Related]

  • 18. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13333-9. PubMed ID: 14715655
    [Abstract] [Full Text] [Related]

  • 19. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 20. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A, Shizume K, Cho M, Takada Y.
    Thromb Res; 1987 Feb 15; 45(4):371-81. PubMed ID: 2437668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.